Skip to main content
Premium Trial:

Request an Annual Quote

IP Roundup: Beacon Biotechnology, Chung Yuan Christian University, Randox, Advanced Technology Applications


Title: Chemiluminescence proximity nucleic acid assay.
Patent Number: 8,735,062
Filed: Dec. 11, 2012
Lead Inventor: Anthony West, Beacon Biotechnology

Title: Biochip array with a three-dimensional structure and method for forming the same.
Patent Number: 8,735,084
Filed: Nov. 15, 2007
Lead Inventor: Yui-Whei Chen-Yang, Chung Yuan Christian University

Title: Sensitive and generic antibodies and multiple applications.
Patent Number: 8,735,556
Filed: June 18, 2012
Lead Inventor: Elouard Benchikh, Randox Laboratories

Title: Electromagnetic biosensor.
Patent Number: 8,735,846
Filed: Oct. 11, 2010
Lead Inventor: Jeffrey Auld, Advanced Technology Applications

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.